We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





New Sperm Analyzer Offers Enhanced Performance, Flexibility, and Standardization

By LabMedica International staff writers
Posted on 28 Jul 2015
A new automated sperm-quality analyzer includes enhancement features such as a high-definition touch-screen interface, expanded testing options, and state-of-the-art digital magnification with “click-to-mark” interface. More...
The analyzer will be exhibited by Medical Electronic Systems (MES; Los Angeles, CA, USA) at the Clinical Lab Expo of AACC 2015 (July 26-30; Atlanta, GA, USA).

The “SQA-Vision” analyzer was developed based on 10 years of market feedback and is positioned to augment MES’s line of SQA-V and QwikCheck semen analyzers with a top of the line solution.

“MES has placed greater than 3,750 semen analyzers globally in over 45 countries. This market penetration provided us with the unique opportunity to develop the SQA-Vision based on a wealth of customer feedback. The SQA-Vision will profoundly impact the way semen analysis is conducted in laboratories worldwide with rapid, standardized and accurate test results, customized reporting and greatly expanded testing options which strictly adhere to WHO guidelines,” said Eric Carver, General Manager.

MES developed the SQA-Vision as an intuitive tool for fertility screening, post-vasectomy follow-up, sperm banking, research or detailed IVF assessment. In addition to the predecessor’s testing modes (Fresh, Washed, Frozen, and Post Vasectomy), the SQA-Vision now includes: Density Gradient, Swim Up, Longevity, and Vitality testing options. It also provides a high-resolution visual interface, barcode scanning technology, built-in LIS capability and click-to-mark counters for assessing both sperm vitality and conducting full differential morphology.

“The beauty of the new SQA-Vision is the blend of updated technology, flexibility, and standardized testing. Depending on how semen analysis is conducted in your laboratory, the Vision can be set-up to operate in a wide range of modes. From fully automated routine screening to intensive IVF workups,” said Marcia Deutsch, CEO.

Related Links:

Medical Electronic Systems
American Association for Clinical Chemistry (AACC)
AACC 2015 Annual Meeting & Clinical Lab Expo



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.